Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Histological Analysis in Renal Transplantation Patients With Deterioration of Graft Function

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2013 by Shanghai Zhongshan Hospital.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Shanghai Zhongshan Hospital Identifier:
First received: February 16, 2013
Last updated: February 20, 2013
Last verified: February 2013
Identify the cause of chronic allograft dysfunction using a combination of comprehensive clinical and histologic information in Chinese renal transplant recipients, then to identify the position of CNI nephrotoxicity in CAD.Chronic allograft dysfunction reflects the dual impact of both immunologic and nonimmunologic (primarily calcineurin inhibitor [CNI]nephrotoxicity) injury. In previous, CNI nephrotoxicity is overstated and considered one of the major causes of CAD, however, recently there has been found most death-censored graft losses to be the result of alloimmune or autoimmune injury, with only a minority of cases attributable to CNI toxicity. Unfortunately, Situation of objective CNI toxicity in CAD in China is not well analyzed. To improve perception of Neo safety with more local evidence, we want to do a retrospective study to identify the cause of chronic allograft dysfunction using a combination of comprehensive clinical and histologic information in Chinese renal transplantation recipients.

Chronic Allograft Dysfunction

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Shanghai Zhongshan Hospital:

Primary Outcome Measures:
  • the graft biopsy of maintenance living donor renal transplant recipients who underwent deterioration of graft function [ Time Frame: up to 6 years ]

Biospecimen Retention:   Samples Without DNA
graft biopsy after kidney transplantation

Estimated Enrollment: 100
Study Start Date: May 2012
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Maintenance living donor renal transplant recipients

Inclusion Criteria:

  • 18 years of age or older
  • Kidney transplant recipients, only including recipients of living-donor grafts
  • Underwent an allograft biopsy between January 2005 and December 2011 because of developing deterioration of graft function*.

    • Deterioration of function was defined as (1) an unexplained and persistent greater than or equal to 25% increase of CR over baseline (in the absence of potential confounding factors) or (2) new onset proteinuria (defined as albumin/CR ratio ≥0.2 or a protein/CR ratio >0.5).

Exclusion Criteria:

  • Multiple organ transplants, prior transplant with any other organ or tissue
  • Patients who did not have the information regarding the pathological diagnosis
  • Patients who did not have the histological sections of the allograft biopsy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01794871

Contact: Tongyu Zhu +8613816002121

China, Shanghai
Zhongshan Hospital, Fudan University Recruiting
Shanghai, Shanghai, China, 200032
Contact: Ming Xu    +86-21-64037269      
Sponsors and Collaborators
Shanghai Zhongshan Hospital
  More Information

Responsible Party: Shanghai Zhongshan Hospital Identifier: NCT01794871     History of Changes
Other Study ID Numbers: COLO400ACN03T
Study First Received: February 16, 2013
Last Updated: February 20, 2013 processed this record on May 25, 2017